0000899243-21-027891.txt : 20210708 0000899243-21-027891.hdr.sgml : 20210708 20210708172131 ACCESSION NUMBER: 0000899243-21-027891 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210706 FILED AS OF DATE: 20210708 DATE AS OF CHANGE: 20210708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sands Capital Ventures Discovery Fund III, L.P. CENTRAL INDEX KEY: 0001870491 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40551 FILM NUMBER: 211081003 BUSINESS ADDRESS: STREET 1: C/O SANDS CAPITAL VENTURES, LLC STREET 2: 1000 WILSON BOULEVARD, SUITE 3000 CITY: ARLINGTON STATE: VA ZIP: 22209 BUSINESS PHONE: 703-562-4000 MAIL ADDRESS: STREET 1: C/O SANDS CAPITAL VENTURES, LLC STREET 2: 1000 WILSON BOULEVARD, SUITE 3000 CITY: ARLINGTON STATE: VA ZIP: 22209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sands Capital Life Sciences Pulse Fund, LLC CENTRAL INDEX KEY: 0001870490 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40551 FILM NUMBER: 211081001 BUSINESS ADDRESS: STREET 1: C/O SANDS CAPITAL VENTURES, LLC STREET 2: 1000 WILSON BOULEVARD, SUITE 3000 CITY: ARLINGTON STATE: VA ZIP: 22209 BUSINESS PHONE: 703-562-4000 MAIL ADDRESS: STREET 1: C/O SANDS CAPITAL VENTURES, LLC STREET 2: 1000 WILSON BOULEVARD, SUITE 3000 CITY: ARLINGTON STATE: VA ZIP: 22209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SANDS FRANK M. CENTRAL INDEX KEY: 0001870494 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40551 FILM NUMBER: 211081000 MAIL ADDRESS: STREET 1: 100 WILSON BLVD STREET 2: SUITE 3000 CITY: ARLINGTON STATE: VA ZIP: 22209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sands Capital Global Venture Fund II, L.P. CENTRAL INDEX KEY: 0001870493 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40551 FILM NUMBER: 211081002 BUSINESS ADDRESS: STREET 1: C/O SANDS CAPITAL VENTURES, LLC STREET 2: 1000 WILSON BOULEVARD, SUITE 3000 CITY: ARLINGTON STATE: VA ZIP: 22209 BUSINESS PHONE: 703-562-4000 MAIL ADDRESS: STREET 1: C/O SANDS CAPITAL VENTURES, LLC STREET 2: 1000 WILSON BOULEVARD, SUITE 3000 CITY: ARLINGTON STATE: VA ZIP: 22209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acumen Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001576885 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 364108129 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4435 NORTH FIRST STREET, SUITE 360 CITY: LIVERMORE STATE: CA ZIP: 94551 BUSINESS PHONE: 925-368-8508 MAIL ADDRESS: STREET 1: 4435 NORTH FIRST STREET, SUITE 360 CITY: LIVERMORE STATE: CA ZIP: 94551 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-06 1 0001576885 Acumen Pharmaceuticals, Inc. ABOS 0001870491 Sands Capital Ventures Discovery Fund III, L.P. 1000 WILSON BLVD., SUITE 3000 ARLINGTON VA 22209 0 0 1 0 0001870493 Sands Capital Global Venture Fund II, L.P. 1000 WILSON BLVD, SUITE 3000 ARLINGTON VA 22209 0 0 1 0 0001870490 Sands Capital Life Sciences Pulse Fund, LLC 1000 WILSON BLVD, SUITE 3000 ARLINGTON VA 22209 0 0 1 0 0001870494 SANDS FRANK M. 1000 WILSON BLVD, SUITE 3000 ARLINGTON VA 22209 0 0 1 0 Common Stock 2021-07-06 4 C 0 1124729 A 1124729 D Common Stock 2021-07-06 4 C 0 1842346 A 2967075 D Common Stock 2021-07-06 4 P 0 450000 14.88 A 3417075 D Series A-1 Preferred Stock 2021-07-06 4 C 0 1124729 D Common Stock 1124729 0 D Series B Preferred Stock 2021-07-06 4 C 0 1842346 D Common Stock 1842346 0 D Each share of Series A-1 Preferred Stock and each share of Series B Preferred Stock automatically converted into one share of Common Stock of the Issuer upon the closing of the Issuer's initial public offering. Represents 225,000 shares of Common Stock acquired by Sands Capital Global Venture Fund II, L.P. ("Sands Venture Fund") and 225,000 shares of Common Stock acquired by ands Capital Life Sciences Pulse Fund ("Sands Pulse Fund") in connection with the closing of the Issuer's initial public offering. Consists of 1,124,719 shares of Common Stock held by Sands Capital Ventures Discovery Fund III, L.P. ("Sands Discovery Fund "). Sands Capital Ventures Discovery Fund III-GP, LLC ("Sands Discovery GP") is the general partner of Sands Discovery Fund. Sands Discovery GP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Consists of 921,173 shares of Common Stock held by Sands Venture Fund and 921,173 shares of Common Stock held by Sands Pulse Fund. Sands Capital Global Venture Fund II-GP, L.P. ("Sands Venture GP L.P.") is the general partner of Sands Venture Fund and Sands Capital Global Venture Discovery Fund II-GP, LLC ("Sands Venture GP LLC") is the general partner of Sands Venture GP L.P. Sands Venture GP L.P. and Sands Venture GP LLC each disclaims beneficial ownership of such securities except to the extent of its respective pecuniary interest therein. Frank M. Sands holds ultimate voting and investment power over securities held by Sands Discovery Fund, Sands Venture Fund and Sands Pulse Fund. Mr. Sands disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. /s/ Jonathan Goodman, General Counsel of Sands Capital Ventures Discovery Fund III-GP, LLC, the General Partner of Sands Capital Ventures Discovery Fund III, L.P. 2021-07-08 /s/ Jonathan Goodman, General Counsel of Sands Capital Global Venture Discovery Fund II-GP, LLC, the General Partner of Sands Capital Global Venture Fund II-GP, L.P., the General Partner of Sands Capital Venture Fund II, L.P. 2021-07-08 /s/ Jonathan Goodman, General Counsel of Sands Capital Life Sciences Pulse Fund, LLC 2021-07-08 /s/ Frank M. Sands 2021-07-08